SEC FORM 4
$23,187.50
Aquestive Therapeutics, Inc. (AQST)
Acquisition (code M) of 8,750 shares at $2.65 per share.
Reporting Person Korczynski Sherry · Officer Title Chief Commercial Officer · Transaction Code M
Traded Sep 9, 2026 · Disclosed Sep 11, 2026
Source: SEC Form 4 · 0001214659-26-011596 · filed 2026-09-11 · View filing →